Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Binod Dhakal

Showing results (31-40 of 178) with videos related to

Pageof 18
Sort By:
Clinical Lymphoma, Myeloma & Leukemia|August 30, 2025
Optimizing Selection of Bridging Therapies Prior to CAR-T Therapy Administration for Multiple Myeloma: Clinical Pearls From an Expert RoundtableSikander Ailawadhi, Larry D Anderson, Binod Dhakal, et al.
JAMA Network Open|October 28, 2022
Kinetics of Humoral Immunodeficiency With Bispecific Antibody Therapy in Relapsed Refractory Multiple MyelomaLindsay R Hammons, Aniko Szabo, Abhishek Janardan, et al.
Haematologica|August 18, 2025
Safety and efficacy of BCMA CAR-T <i>vs.</i> bispecific antibodies in patients with relapsed multiple myeloma: a systematic review and meta-analysisHayley Vandenboom, Othman Akhtar, Aniko Szabo, et al.
British Journal of Haematology|April 8, 2017
Marizomib for central nervous system-multiple myelomaAshraf Badros, Zeba Singh, Binod Dhakal, et al.
Journal of Geriatric Oncology|June 10, 2020
Efficacy and safety of frontline regimens for older transplant-ineligible patients with multiple myeloma: A systematic review and meta-analysisSmith Giri, Madan Raj Aryal, Han Yu, et al.
Clinical Lymphoma, Myeloma & Leukemia|July 23, 2024
Safety of Dapsone for Pneumocystis Jiroveci Pneumonia Prophylaxis in Patients With Multiple MyelomaMingee Kim, Jessica Arabi, Cole McCoy, et al.
Hematology/Oncology and Stem Cell Therapy|March 19, 2019
Acquired factor X deficiency in light-chain (AL) amyloidosis is rare and associated with advanced diseaseGina Patel, Parameswaran Hari, Aniko Szabo, et al.
Southern Medical Journal|October 5, 2018
Risk, Outcomes, and Predictors of <i>Clostridium difficile</i> Infection in Lymphoma: A Nationwide StudySanjay Bhandari, Ramesh Kumar Pandey, Sumit Dahal, et al.
The Journal of Thoracic and Cardiovascular Surgery|April 27, 2013
Morbidities of lung cancer surgery in obese patientsBinod Dhakal, Daniel Eastwood, Sunitha Sukumaran, et al.
Molecular Cancer Therapeutics|January 28, 2022
Critical Role for Cap-Independent c-MYC Translation in Progression of Multiple MyelomaYijiang Shi, Fumou Sun, Yan Cheng, et al.
Pageof 18

Showing results (31-40 of 178) with videos related to

Sort By:
Pageof 18
Clinical Lymphoma, Myeloma & Leukemia|August 30, 2025
Optimizing Selection of Bridging Therapies Prior to CAR-T Therapy Administration for Multiple Myeloma: Clinical Pearls From an Expert RoundtableSikander Ailawadhi, Larry D Anderson, Binod Dhakal, et al.
JAMA Network Open|October 28, 2022
Kinetics of Humoral Immunodeficiency With Bispecific Antibody Therapy in Relapsed Refractory Multiple MyelomaLindsay R Hammons, Aniko Szabo, Abhishek Janardan, et al.
Haematologica|August 18, 2025
Safety and efficacy of BCMA CAR-T <i>vs.</i> bispecific antibodies in patients with relapsed multiple myeloma: a systematic review and meta-analysisHayley Vandenboom, Othman Akhtar, Aniko Szabo, et al.
British Journal of Haematology|April 8, 2017
Marizomib for central nervous system-multiple myelomaAshraf Badros, Zeba Singh, Binod Dhakal, et al.
Journal of Geriatric Oncology|June 10, 2020
Efficacy and safety of frontline regimens for older transplant-ineligible patients with multiple myeloma: A systematic review and meta-analysisSmith Giri, Madan Raj Aryal, Han Yu, et al.
Clinical Lymphoma, Myeloma & Leukemia|July 23, 2024
Safety of Dapsone for Pneumocystis Jiroveci Pneumonia Prophylaxis in Patients With Multiple MyelomaMingee Kim, Jessica Arabi, Cole McCoy, et al.
Hematology/Oncology and Stem Cell Therapy|March 19, 2019
Acquired factor X deficiency in light-chain (AL) amyloidosis is rare and associated with advanced diseaseGina Patel, Parameswaran Hari, Aniko Szabo, et al.
Southern Medical Journal|October 5, 2018
Risk, Outcomes, and Predictors of <i>Clostridium difficile</i> Infection in Lymphoma: A Nationwide StudySanjay Bhandari, Ramesh Kumar Pandey, Sumit Dahal, et al.
The Journal of Thoracic and Cardiovascular Surgery|April 27, 2013
Morbidities of lung cancer surgery in obese patientsBinod Dhakal, Daniel Eastwood, Sunitha Sukumaran, et al.
Molecular Cancer Therapeutics|January 28, 2022
Critical Role for Cap-Independent c-MYC Translation in Progression of Multiple MyelomaYijiang Shi, Fumou Sun, Yan Cheng, et al.
Pageof 18